Company news

Fusion Antibodies Plc (LSE:FAB) news

Fusion Antibodies Plc news releases on 6ix. Latest, Apr 16, 2024: Change of auditor

View Fusion Antibodies Plc →

Press releases — page 2

Change of auditor

April 16, 2024

Contract to develop a bespoke OptiPhage library

April 15, 2024

Result of General Meeting and Total Voting Rights

March 5, 2024

First purchase order under MSA

February 27, 2024

Grant of options and issue of shares to directors

February 14, 2024

Placing to raise £1,375,000

February 14, 2024

Follow-on project award and R&D update

February 6, 2024

HMRC R&D tax credit

February 1, 2024

Fusion Antibodies : Interim Report 2023

December 4, 2023

OptiMAL collaboration agreement

November 28, 2023

Half year trading update

November 9, 2023

Update on AI/ML-Ab service offering

August 29, 2023

Appointment of interim CFO

August 24, 2023

Update on AI/ML-Ab™ antibody discovery service

August 21, 2023

Update on restructure and cost savings

August 14, 2023

Result of GM and total voting rights

June 8, 2023

Result of Retail Offer and Notice of GM

May 23, 2023

REX Retail Offer

May 19, 2023

Placing, Subscription and Retail Offer

May 19, 2023

Block listing Interim Review

April 3, 2023

Change of Registered Office

March 31, 2023

Patent application

March 21, 2023

Second Price Monitoring Extn

March 6, 2023

Price Monitoring Extension

March 6, 2023

Trading Statement

March 6, 2023

R&D update: Mammalian Display service

February 9, 2023

Fusion Antibodies : Interim Report 2022

December 5, 2022

Grant of options

September 15, 2022

Notice of AGM and Director change

September 1, 2022

Fusion Antibodies : Annual Report & Account 2022

August 25, 2022

Bispecific designs patent application

August 9, 2022

Appointment of Chief Executive Officer

July 28, 2022

Update on Board changes

March 14, 2022

Director changes

February 28, 2022

Directorate Change

February 21, 2022

Stmnt re Share Price Movement

February 10, 2022

Formation of New Scientific Advisory Panel

January 14, 2022

Exercise of share options and total voting rights

December 16, 2021

Update on R&D

December 2, 2021

New contract win

October 7, 2021

AGM Statement

September 24, 2021

Collaboration with Eurofins Discovery

August 24, 2021

Exercise of Options and Total Voting Rights

August 10, 2021

Successful milestone payment

July 23, 2021

Exercise of options

May 5, 2021

Receipt of grants from Invest Northern Ireland

October 27, 2020

Update on R&D programme

September 18, 2020

Queens University Belfast funding

August 11, 2020

Exercise of Options

July 7, 2020

Result of General Meeting & Total Voting Rights

May 15, 2020

← Newer · Older →